Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.
about
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisAdjuvant treatment for older women with invasive breast cancerWhen are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Tamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding.Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomyThe Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers.The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleClustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006Lack of survival gain for elderly women with breast cancer.Approach to chemotherapy-associated thrombosis.Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?Just another negative DVT?Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.The importance of nonpharmacogenetic factors in endocrine therapy.The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis.Heparanase procoagulant activity is elevated in women using oral contraceptives.Branch retinal vein occlusion associated with tamoxifen use.Guideline on aspects of cancer-related venous thrombosis.Comprehensive review of cardiovascular toxicity of drugs and related agents.The anticancer estrogen receptor antagonist tamoxifen impairs consolidation of inhibitory avoidance memory through estrogen receptor alpha.Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.Death causes in breast cancer patients.Thrombosis and cancerLong term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic reviewNo increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
P2860
Q27005043-B7215410-C550-48E8-915E-F9785DFA0F88Q28066744-B76E4ABF-D15F-4FDF-BF89-C71B46C820B7Q31024426-558B2D1C-A357-4AB7-B3EC-DE55F4E09078Q33166159-4C1899C4-74C7-42AF-B044-5151FCF19A06Q33622316-719135DC-850F-494A-92EC-722F104E53BEQ33735382-D284A84B-4BC3-4463-BAE9-96A3CC7DAEE5Q33861668-6E00D981-6A19-465D-A8F2-6F896361A40CQ34130749-9E8EDC85-9541-4D27-B189-CDF7D52EA8F8Q34250240-1BE8C678-BEBE-425C-97C0-B791C6B6E74CQ35584585-EE036566-E6E5-4AED-AC6E-A343E6376CB3Q36304793-B1428C56-7D57-4A22-89A7-D74385AB7B49Q36618977-A7FD8A11-E704-4B66-AF55-B8590D3F2B5BQ37223803-24FA66CF-7E30-4035-BEE3-84C086E7B88EQ37350988-82DF22A9-BB4E-44CB-A0D1-49855AEA255CQ37577731-DA21C737-A831-4102-86F0-CE7B69CD6D44Q38003706-63289848-1F73-4C21-8DE2-95F69A9B6891Q38175883-9C999EF5-BC1E-4587-B0F6-206F727ADF03Q38381351-A6FF821D-1C1E-4248-9537-E8FB124A8FF1Q38674583-32FDC181-7E27-4535-899F-6BCD500DFE3FQ38968554-E1619E84-9697-482F-8C58-6865E6AA3E86Q39135103-DD82ECDE-C51E-4E7D-9F88-23CC2FFA3650Q45258241-628D17D7-E52A-4DBD-A548-917ABDDDD282Q45877193-647A2BE6-132B-4FC7-AC10-F891ED8CE56BQ47556269-36AEA022-1302-4D19-BD79-CF0292B4CE66Q47653282-12DCF4E9-E4D3-44A5-8476-371BDA202562Q48068071-2C640375-686E-418F-9ABF-F1945B20678EQ48869594-9581BB82-ED54-4421-A6C4-FD9597B6F80FQ56339353-558A07C4-B2DE-45E0-8AF4-86BB6518822CQ57293528-735D7313-1EFD-47BA-BC09-C5ECF3C531BFQ58215078-2C501FC5-8043-4C67-8A4C-6751B39884B1
P2860
Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Tamoxifen treatment and risk o ...... population-based cohort study.
@en
Tamoxifen treatment and risk o ...... population-based cohort study.
@nl
type
label
Tamoxifen treatment and risk o ...... population-based cohort study.
@en
Tamoxifen treatment and risk o ...... population-based cohort study.
@nl
prefLabel
Tamoxifen treatment and risk o ...... population-based cohort study.
@en
Tamoxifen treatment and risk o ...... population-based cohort study.
@nl
P2093
P356
P1433
P1476
Tamoxifen treatment and risk o ...... population-based cohort study.
@en
P2093
Jacob Jacobsen
Lars Pedersen
Rohini K Hernandez
Timothy L Lash
P304
P356
10.1002/CNCR.24508
P407
P577
2009-10-01T00:00:00Z